Aug 2026· Small· pp.
e74840
· 0 citations· 34 references
Medicine
Abstract
Electrocatalytically amplified electrochemical immunosensing is a powerful strategy for sensitive and interference-free detection of biomarkers. Herein, we report a high-performance electrochemical immunosensor enabled by a hierarchical hybrid architecture comprising Ru nanodots anchored on titanium oxynitride nanoflakes dispersed on graphene oxide (Ru/TiON-GO), linked via APTES to biorecognition building blocks. The engineered heterostructure exhibits advanced electrocatalytic activity, arising from synergistic electronic coupling between Ru nanodots and the highly conductive TiON-GO support, effectively promoting interfacial electron transport between the electrocatalytic surface and the [Fe(CN)6]3-/4- redox probe. Leveraging this electrocatalytic platform, a prostate-specific antigen (PSA) impedimetric immunosensor was constructed, achieving a limit of detection of 0.06 ng mL-1 (2.3 pM) and a wide linear response covering clinically relevant concentration range. The immunosensor demonstrates excellent selectivity in human serum, operating in interference-free mode even in the presence of common coexisting biomolecules, highlighting suitability for medical diagnostics. Density functional theory calculations further elucidate the origin of the enhanced electrocatalytic performance, with charge density difference plots and density of states analysis revealing Ru-driven electron redistribution and increased density of states near the Fermi level. This work establishes the Ru/TiON-GO nanocomposite as a robust electrocatalytic platform for advanced immunosensing applications, paving the way toward next-generation electrochemical diagnostic devices.
A cascade-driven dual-signal attenuation strategy that holds great promise for high‑performance electrochemical biosensing in complex biological samples.
Ge Song, Jiaqing Wang, Xianrui Jiang et al.· Analytical and Bioanalytical...· 0 citations
In this work, a sensitive electrochemiluminescence (ECL) sensing platform was developed for the determination of trilobatin (Tri) using a ZnPTC@MoS2-modified glassy carbon electrode. In this sensing interface, ZnPTC acts as both an intrinsically ECL-active metal-organic framework and a structural scaffold, while MoS2 nanosheets promote interfacial electron transfer and facilitate the electroreduction of persulfate. The synergistic integration of ZnPTC and MoS2 effectively alleviates the restacking of MoS2 nanosheets, improves charge-transfer kinetics, and significantly enhances the ECL response of the composite. Under the optimized experimental conditions, the change in ECL intensity showed a good linear relationship with the logarithm of Tri concentration over the range of 5.0 × 10-8-1.0 × 10-3 M, with a detection limit of 5.6 × 10-9 M. The proposed ECL sensor exhibited good selectivity, reproducibility, operational stability, and long-term stability. Moreover, the method was successfully applied to the determination of Tri in real samples, affording recoveries of 98.98-103.66% with relative standard deviations below 2.50%. These results demonstrate that the ZnPTC@MoS2-based ECL platform provides a promising analytical strategy for sensitive Tri determination in practical samples.
Xiaohui Chen, Xue Mei, Wen-Chang Wang et al.· In Analysis· 0 citations
A sensitive and label-free electrochemical immunosensor based on a g-C₃N₄/MgO nanocomposite-modified electrode for the selective detection of CYFRA21-1 has great promise for clinical diagnosis and point-of-care detection of lung cancer biomarkers because of its affordability, simplicity, and sensitivity.
Pooja Rahar, Saravjeet Singh· Journal of nanoparticle rese...· 0 citations